Mather Group’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-355
| Closed | -$2.66K | – | 713 |
|
|
2025
Q1 | $2.66K | Buy |
+355
| New | +$2.66K | ﹤0.01% | 1524 |
|
|
2024
Q3 | – | Sell |
-355
| Closed | -$1.8K | – | 1757 |
|
|
2024
Q2 | $1.8K | Buy |
355
+155
| +78% | +$787 | ﹤0.01% | 1910 |
|
|
2024
Q1 | $1.2K | Buy |
+200
| New | +$1.2K | ﹤0.01% | 1605 |
|